INSEEGO CORP. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data INSEEGO CORP. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	244	219	202	219	314	262	245	167	191	166
Cost of revenue	167	152	132	156	223	186	178	132	122	95.2
Gross profit	76.3	67.3	70.6	64	90.8	75.9	66.9	35.8	68.8	71
Research and development	30.7	21.4	20.6	23.9	45	52.7	38.3	19.7	20.6	19.8
Selling and marketing	29.8	25	23	28.9	35.8	38.2	32.8	16.6	16	17.4
General and administrative	52.4	34.4	25.3	27.3	30.7	28.3	26.2	15.9	17.2	20.8
Operating expenses	121	89.5	56.6	83.5	116	122	125	71.7	67.1	66.7
Operating income	-45	-22.2	14	-19.5	-25.1	-46.5	-57.9	-36	1.72	4.32
Other non-operating income	0.41	-4.08	-0.9	0.35	0.99	0.85	-1.91	0.07	-0.85	0.74
Pre-tax income	-60.2	-45.6	-7.33	-39.6	-110	-47.7	-68.4	-45	-13.7	1.28
Income tax	0.38	0.21	0.82	0.54	0.75	0.19	-0.47	0.04	0.69	0.04
Income from continuing operations								-45	-14.4	1.24
Net income to minority interests	0.01	-0.11	-0.09	0.02	0.03	0.21	0
Net income	-60.6	-45.7	-8.06	-40.1	-111	-48.1	-68	-46.2	4.57	0.84
EBITDA	-31	-7.94	27.7	-1.12	2.81	-21.2	-30.7	-17.2	14.2	12.8
EPS, basic	-11.18	-7.79	-1.20	-5.19	-11.88	-5.09	-6.59	-4.32	0.10	-0.18
EPS, diluted	-11.18	-7.79	-1.20	-5.19	-11.88	-5.09	-6.59	-4.32	0.10	-0.18
Shares, basic (weighted)	5.4	5.88	6.62	7.84	9.63	10.3	10.7	11.4	12.5	15.1
Shares, diluted (weighted)	5.4	5.88	6.62	7.84	9.63	10.3	10.7	11.4	12.5	15.1

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	9.89	21.2	31	12.1	40	46.5	7.14	2.41	39.6	24.9
Short-term investments	0
Receivables	22.2	15.7	20.6	19.7	29.9	26.8	25.3	18.2	13.8	25.1
Inventory	31.1	20.4	26.4	25.3	34	37.4	38	20.6	13.6	7.73
Other current assets	5.21	9.1	6.21	7.12	10.2	13.6	7.98	4.94	5.93	6.39
Total current assets	68.4	66.4	84.4	64.1	114	128	78.4	58.2	72.9	64.1
Property, plant and equipment	8.39	6.99	6.7	10.8	13.7	8.1	5.39	2.39	1.1	1.09
Lease right-of-use assets				2.66	9.09	7.84	6.66	4.02	2.86	3.45
Goodwill	34.4	37.7	32.9	33.7	32.5	20.3	21.9	3.95	3.95	3.95
Intangible assets	40.3	38.7	32	44.4	51.5	47	41.4	25.7	18.7	20.7
Other non-current assets	0.16	0.86	0.51	0.39	0.39	0.38	1.42	1.26	0.45	0.56
Total assets	159	158	162	161	227	216	160	122	100	93.8
Accounts payable	31.2	29.3	39.2	26.5	52.3	48.6	29	23.4	18.4	23.6
Accrued liabilities	27.9	27.6	13	18	23.4	26.3	27.9	21	30.1	24.9
Deferred revenue						0	2.83	0	9.25
Short-term debt								0
Total current liabilities	62.4	60	53.7	44.5	75.7	74.8	57	55.9	63.5	48.4
Lease liabilities				1.71	8.29	7.11	5.9	3.97	2.63	2.91
Other non-current liabilities	18.7	9.77	2.54	2.38	9.93	7.15	0.6	2.35	4.76	4.71
Total liabilities	176	204	199	199	255	241	230	224	113	97.9
Total debt	121	153	153	153
Paid-in capital	508	520	546	585	711	771	794	810	893	904
Retained earnings	-524	-570	-578	-618	-732	-787	-858	-907	-906	-908
Other comprehensive income	-1.41	4.6	-4.88	-3.88	-6.97	-8.53	-6.33	-5.33	0.22	0.4
Shareholders' equity	-17.8	-45.6	-36.4	-37.2	-27.8	-24.9	-70.1	-102	-12.9	-4.04
Minority interests	0.04	-0.05	-0.14	-0.12	-0.09	0
Total equity	-17.7	-45.6	-36.5	-37.4	-27.9	-24.9	-70.1	-102	-12.9	-4.04
Total liabilities and equity	159	158	162	161	227	216	160	122	100	93.8
Shares outstanding	5.45	5.87	7.41	8.21	9.95	10.6	10.8	11.9	15	15.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-60.6	-45.8	-8.14	-40.1	-111	-47.9	-68	-46.2	4.57	0.84
Depreciation and amortization	14.1	14.3	13.7	18.4	27.9	25.3	27.2	18.7	12.5	8.45
Stock-based compensation	4.59	3.75	4.88	7.3	10.4	16.6	17.9	6.97	3.82	7.44
Deferred income tax	0.2	0.32	0.01	-0.6	0.66	-0.05	-0.57	0.01	0.06	0.01
Change in receivables	11.6	5.64	-6.88	0.38	-10.8	-1.15	2.44	3.07	4.67	-11.6
Change in inventory	-3.16	3.02	-11.4	-3.08	-13.3	-12.5	-3.07	4.27	6.92	7.45
Change in payables	-7.83	-0.73	9.65	-13	27.1	-3.11	-26.3	-0.8	-6.95	3.68
Cash from operations	-6.58	-14.6	-1.77	-18	20.1	-25.2	-33.3	5.96	33.5	7.2
Capital expenditures	-1.44	-1.79	-1.34	-6.62	-5.74	-4.93	-1.48	-0.22	-0.1	-0.66
Acquisitions	-3.75	0
Purchases of investments	0
Sales and maturities of investments	0
Cash from investing	5.04	-4.38	-4.23	-28.2	-34.7	6.08	-13.3	-10.2	43	-8.57
Debt issued	0	64.9	0
Stock issued				0	0	29.4	0	6.06	0
Cash from financing	-1.29	30.4	17.7	27.5	42.1	29.9	5.43	2.21	-38.8	-13.4
Exchange rate effect	0.16	-0.05	-1.85	-0.26	0.52	-0.99	-1.49	1.17	-0.58	0.09
Net change in cash	-2.68	11.4	9.82	-19	27.9	9.8	-42.7	-0.83	37.2	-14.7
Free cash flow	-8.02	-16.4	-3.1	-24.6	14.3	-30.1	-34.8	5.73	33.4	6.53
Interest paid	7.14	9.07	10.6	9.3	3.22	5.39	5.54	6.01	6.25	3.95
Income taxes paid	0.12	0.44	0.67	0.94	0.14	0.52	0.17	0.14	0.2	1.36

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.76 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	41.1%	Gross profit / revenue.
Operating margin	-4.3%	Operating income / revenue.
EBITDA margin	0.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-6.4%	Pre-tax income / revenue.
Net margin	-6.4%	Net income / revenue.
FCF margin	-4.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-4.0%	Cash from operations / revenue.
Return on assets (ROA)	-12.3%	Net income / average total assets.
R&D / revenue	12.5%	Research and development expense / revenue.
Stock-based pay / revenue	5.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	5.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-13.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-12.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-11.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	2.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-4.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	151.7%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-10.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y	35.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-81.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-280.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-78.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-18.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-80.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-14.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-6.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-16.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-16.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	20.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	12.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	9.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.07x	Current assets / current liabilities.
Quick ratio	0.77x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	133.8%	Total liabilities / total assets.
Working capital	$3.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	30.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$57.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.91x	Revenue / average total assets.
Fixed asset turnover	131x	Revenue / average property, plant and equipment.
Inventory turnover	11.4x	Cost of revenue / average inventory.
Days inventory	32 days	365 x average inventory / cost of revenue.
Receivables turnover	4.30x	Revenue / average receivables.
Days sales outstanding	85 days	365 x average receivables / revenue.
Days payables	103 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	14 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.68	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$10.58	Revenue / diluted weighted shares.
FCF per share	-$0.48	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.42	Cash from operations / diluted weighted shares.
Book value per share	-$1.86	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$3.53	Tangible book value / shares outstanding.
Cash per share	$0.11	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$61.7M	Share price x shares outstanding.
Enterprise value	$59.9M	Market cap + total debt - cash - short-term investments.
P/S	0.36x	Market cap / revenue.
EV/Sales	0.35x	Enterprise value / revenue.
EV/EBITDA	48.0x	Enterprise value / EBITDA, when both are positive.
FCF yield	-12.7%	Free cash flow / market cap.
Earnings yield	-17.9%	Net income / market cap (the inverse of P/E).

What was INSEEGO CORP.'s revenue in fiscal 2025?

INSEEGO CORP. reported revenue of $166.2M for fiscal 2025, 13.1% lower than the year before.

Was INSEEGO CORP. profitable in fiscal 2025?

Yes. Net income was $838.0K, a net margin of 0.5%.

How much free cash flow did INSEEGO CORP. generate in fiscal 2025?

Cash from operations of $7.2M minus capital expenditures of $661.0K left free cash flow of $6.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INSEEGO CORP.